Statistics
Publications
43
Citations
3.6K
H-Index
33
Active since
2012
Dongwen Lv is an author at Capital Normal University specializing in life sciences, plant biology, and plant proteomics.
Publications per year
2012–2025
43
43
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan, Xuan Zhang, Dongwen Lv et al. · Nature Medicine · 2019 · 647 citations · Full text
Medicine, Oncology, Pharmacology +7
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,
Dongwen Lv, Pratik Pal, Xingui Liu et al. · Nature Communications · 2021 · 148 citations · Full text
1–5 of 43